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Cell death linked to oxidative DNA damage has been
implicated in acute pancreatitis. The severe DNA dam-
age, which is beyond the capacity of the DNA repair
proteins, triggers apoptosis. It has been hypothesized
that oxidative stress may induce a decrease in the Ku70
and Ku80 levels and apoptosis in pancreatic acinar cells.
In this study, it was found that oxidative stress caused
by glucose oxidase (GO) acting on -D-glucose, glucose/
glucose oxidase (G/GO), induced slight changes in cyto-
plasmic Ku70 and Ku80 but drastically induced a de-
crease in nuclear Ku70 and Ku80 both time- and
concentration-dependently in AR42J cells. G/GO in-
duced apoptosis determined by poly(ADP-ribose) poly-
merase cleavage, an increase in expression of p53 and
Bax, and a decrease in Bcl-2 expression. G/GO-induced
apoptosis was in parallel with the loss of nuclear Ku
proteins in AR42J cells. Caspase-3 inhibitor prevented
G/GO-induced nuclear Ku loss and cell death. G/GO did
not induce apoptosis in the cells transfected with either
the Ku70 or Ku80 expression gene but increased apop-
tosis in those transfected with the Ku dominant nega-
tive mutant. Pulse and pulse-chase results show that
G/GO induced Ku70 and Ku80 syntheses, even though
Ku70 and Ku80 were degraded both in cytoplasm and
nucleus. G/GO-induced decrease in Ku binding to impor-
tin  and importin  reflects possible modification of
nuclear import of Ku proteins. The importin  level was
not changed by G/GO. These results demonstrate that
nuclear decrease in Ku70 and Ku80 may result from the
decrease in Ku binding to nuclear transporter importins
and the degradation of Ku proteins. The nuclear loss of
Ku proteins may underlie the mechanism of apoptosis in
pancreatic acinar cells after oxidative stress.
Oxidative stress is regarded as a major pathogenic factor in
acute pancreatitis (1). This hypothesis was demonstrated by
the high levels of lipid peroxide, which is an index of oxidative
membrane damage, in the serum of the patients with acute
pancreatitis (2). Scavenger therapy for reactive oxygen species
(ROS)1 has attained some success in experimental pancreatitis
models (1, 3, 4). In human acute pancreatitis, the increased
levels of lipid peroxidation products in the bile or pancreatic
tissue (5–7) and the subnormal levels of antioxidant vitamins
in the blood (8, 9) have been reported. Once produced, ROS can
act as a molecular trigger for various inflammatory processes.
They can attack the biological membranes directly and trigger
the accumulation of neutrophils (10) and their adherence to the
capillary wall (11). Therefore, it is probable that ROS play a
central role in perpetuating the pancreatic inflammation and
the development of extrapancreatic complications (12).
Inflammation and acinar cell death are the hallmarks of both
human and experimental pancreatitis (13, 14). Although sig-
nificant progress in understanding the inflammatory response
has been achieved over the past decade, the mechanisms of
acinar cell death in pancreatitis remain largely unexplored. In
pancreatitis, acinar cell death occurs by both necrosis and
apoptosis (15–18). Apoptosis is a programmed form of cell
death that is characterized by a series of distinct morphological
and biochemical changes including the condensation of nuclear
chromatin and DNA fragmentation that occurs in response to a
variety of stress-related stimuli (19, 20). One report suggested
that severe forms of acute pancreatitis involve primarily necro-
sis, whereas the mild forms predominantly involve apoptosis
and marginal amounts of necrosis of the exocrine pancreatitis
(18). Recent studies have revealed that apoptosis is a major
mechanism of acinar cell death in various experimental models
of acute pancreatitis, suggesting a role for apoptosis in the
pathophysiology of the disease (21, 22). The molecular mecha-
nisms responsible for apoptosis in pancreatic acinar cells re-
main to be defined.
The Ku70 (70 kDa) and Ku80 (80 kDa) proteins are DNA-
binding regulatory subunits of DNA-dependent protein kinase
(DNA-PK) that are composed of a 470-kDa catalytic subunit
(DNA-PKcs) and Ku proteins (23, 24). The Ku70 and Ku80
proteins act as the regulatory parts of the DNA-PK and initiate
the repair process of DNA double-stranded breaks, which pro-
duce DNA fragmentation, by activating DNA-PK after binding
to the DNA double-stranded breaks (23). In addition to the
regulatory function of the Ku proteins in DNA-PK, het-
erodimers of both Ku70 and Ku80 also have independent DNA
repair functions. These include single-stranded DNA-depend-
ent ATPase activity and the binding and repair of broken
single-stranded DNA, single-stranded nicks, gaps in DNA, and
single-stranded to double-stranded transitions in DNA (23, 24).
Oxidative damage to nucleic acids can produce adducts of the
base residues and sugar residues, which may lead to the gen-
eration of single-stranded breaks. Less frequently, oxidation
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can cause cross-links to other molecules and double-stranded
breaks (25). Oxidative injury caused by ischemia/reperfusion in
the rabbit spinal cord induces reversible neurological deficits
with increased Ku-DNA binding activity, which is an indicator
of a DNA-PK activation, whereas severe ischemia/reperfusion
causes permanent deficits that are accompanied by decease in
the Ku-DNA binding activity. This suggests that Ku has a
defensive role against oxidative injury (26). Embryo fibroblasts
derived from Ku80-null (Ku80/) mice were more susceptible
to H2O2-triggered DNA damage than those from the wild-type
mice (27). Therefore, it is assumed that Ku may play a role in
the cell death mechanisms, particularly DNA fragmentation
after oxidative stress, and that Ku reduction may involve the
mechanism of apoptotic cell death.
Several protease families are implicated in apoptosis, the
most prominent being caspase (28). Caspases are cysteine-
containing, aspartic acid-specific proteases that exist as zymo-
gens in the soluble cytoplasm, the mitochondrial intermem-
brane space, and the nuclear matrix of virtually all cells (29).
Upon activation, the caspases cleave numerous cellular pro-
teins, including poly(ADP-ribose) polymerase (PARP) (29). In
fact, almost 100 cellular proteins have now been identified as
potential caspase substrates during apoptosis, and most events
in apoptosis appear to require a caspase-mediated proteolytic
process (30). The 460-kDa catalytic subunit of DNA-PK is also
substrate for caspase-3, which is activated by ischemia/reper-
fusion (26) and ROS (31–36). The reduction in the Ku-DNA
binding activity (which is critical to DNA PK activation) after
prolonged ischemia, which is accompanied by a reduction in the
Ku protein and the proteolysis of PARP, suggests that a reduc-
tion in Ku might be involved downstream from the caspase-
activating apoptotic pathway after ischemia/reperfusion (26).
Moreover, four nucleoporins, Nup153, RanBP2, Nup214, and
Tpr are cleaved by caspases during apoptosis (37). Nuclear
transport factors, Ran, importin , and importin  are not
proteolytically processed but redistribute across the nuclear
envelope independently and prior to caspase activation (37).
Macromolecules with a molecular mass greater than 40–60
kDa enter the nucleus via active transport (38). This transport
route requires an adaptor protein, importin , that links the
nuclear cargo to importin . This classical nuclear protein
import requires energy, soluble transport factors, and nuclear
localization sequences (NLSs), specialized signals that target
proteins into the nucleus. In classical nuclear transport, these
signals can be of two types: monopartite or bipartite. Monopar-
tite signals are simple stretches of basic amino acids, whereas
bipartite NLSs contain two clusters of basic amino acids sepa-
rated by a spacer region (39). The structure of the Ku70 NLS
resembles the consensus of a bipartite-type NLS (40). Both
Ku70 NLS and Ku80 NLS are mediated to target to the nuclear
rim by two compartments of the nuclear pore-targeting com-
plex, importin  and importin  (40, 41). Because the integrity
of the nuclear pore may be essential for nucleocytoplasmic
transport, caspase-mediated cleavage of nucleoporins may in-
terfere nuclear translocation of Ku70 and Ku80 during apo-
ptosis. Modifications in the machinery responsible for nucleo-
cytoplasmic transport, such as redistribution of Ran, importin
, and importin  between the nucleus and the cytoplasm, may
inhibit nuclear import of Ku proteins during apoptosis.
This study investigates the role of Ku70 and Ku80 on apo-
ptotic cell death, which is induced by oxidative stress in pan-
creatic acinar AR42J cells. To explore the changes in the Ku
proteins in the cell death pathway after oxidative stress, the
Ku expression level, cell viability, and apoptosis were deter-
mined before and after treatment with H2O2. H2O2 is continu-
ously generated by glucose oxidase (GO) acting on -D-glucose,
which is expressed as glucose/glucose oxidase (G/GO). To de-
termine the apoptotic cleavage of Ku, Ku expression, the intra-
cellular distribution, and the cell viability were determined in
the cells treated with G/GO in the presence or absence of the
caspase-3 inhibitor. In addition, the cell viability and DNA
fragmentation were compared among the wild-type cells, and
the cells transfected with the pcDNA expression vector (pcN-3),
the Ku dominant negative mutant (KuD/N), or either the Ku70
or Ku80 expression gene (Ku70, Ku80) treated with G/GO.
Transfection was confirmed by an increase in Ku expression in
the cells transfected with Ku70 or Ku80. Functional effi-
ciency was determined by a loss of Ku-DNA binding activity in
the cells transfected with KuD/N. As the apoptotic indices,
PARP cleavage and the expression changes in p53, Bcl-2, and
Bax were monitored in the wild-type cells treated with G/GO.
To determine the effect of G/GO on Ku synthesis and degrada-
tion, the wild-type cells were pulsed or pulse-chased with
[35S]methionine with or without the G/GO treatment and im-
munoprecipitated with anti-Ku70 or anti-Ku80 antibodies. To
determine whether nuclear import of Ku proteins is inhibited
by G/GO, in vitro binding assay using glutathione S-transfer-
ase (GST)-importin  fusion protein was performed in the wild-
type cells treated with G/GO. The bound protein levels were
determined by Western blotting for Ku70, Ku80, and importin
. The importin  level was monitored in the wild-type cells
treated with or without G/GO.
EXPERIMENTAL PROCEDURES
Cell Lines and Culture Condition—The rat pancreatic acinar AR42J
cells (pancreatoma, ATCC CRL 1492) were obtained from the American
Type Culture Collection (Manassas, VA) and cultured in Dulbecco’s
modified Eagle’s medium (Sigma) supplemented with 10% fetal bovine
serum (Invitrogen) and antibiotics (100 units/ml penicillin and 100
g/ml streptomycin).
Plasmid Construction—The human cDNA for Ku70 and Ku80 was
derived from human Ku70/pET1a and Ku80/pET1a, respectively. The
insert was digested with BamHI and EcoRI and subcloned into the
BamHI-EcoRI sites of the pcDNA3 vector (Invitrogen), which was used
for the Ku70 or Ku80 expression plasmid construct (as Ku70 or
Ku80). A C-terminal human Ku80 (427–732) expression vector was
generated by PCR using the Ku80 cDNA vector with a specific set of
primers to generate the artificial KpnI and BamHI sites at the 5 and 3
ends, respectively. The sequences of the primers used are as follows:
5-TGCAGGTACCTATCATGGAAGACTTGCG-3 and 5-GGTACCTA-
GGTGCTGGATATAGTACAGG-3. A KpnI-BamHI fragment of the
product was subcloned into the KpnI and BamHI sites of the pcDNA3
vector, which was used for the C-terminal Ku80 (427–732) expression
plasmid construct (as KuD/N). The PCR-derived part was confirmed by
sequencing analysis. For in vitro binding assay, cDNA fragment en-
coding for the full-length rat importin- was amplified by PCR and
subcloned into the BamHI-XhoI site of pGEX-5X-1 (Amersham
Biosciences).
Transfection—Subconfluent AR42J cells, plated in a 10-cm culture
dish, were transfected with each 10 g of the pcDNA-3 vector (as
pcDNA), the C-terminal Ku80 (427–732) expression plasmid construct
(as KuD/N), the Ku70 or Ku80 expression plasmid construct (as Ku70
or Ku80) using N-[1-(2,3-dioleoyloxy) propyl]-N,N,N-trimethyl ammo-
nium methylsulfate (Roche Applied Science) for 16 h. After transfection,
the cells were trypsinized and plated at 3 104 cells/10-cm culture dish.
The cells were then cultured overnight and treated with or without
G/GO (5 milliunits) for 12 h. The cytoplasmic and nuclear extracts were
prepared from the cells. The Ku70 and Ku80 protein levels were deter-
mined by Western blot analysis (see Fig. 6). The functional efficiency of
the C-terminal Ku80 (427–732) expression gene was examined by de-
termining the Ku-DNA binding activity with an electrophoretic mobil-
ity shift assay (see Fig. 7). Transfection efficiency of the C-terminal
Ku80 (427–732) expression gene using polyclonal antibody for Ku80
could not be determined by Western blot analysis (data not shown) as
previously reported (42).
Experimental Protocol—To determine whether H2O2 induces apo-
ptosis in pancreatic acinar cells and whether the changes in the Ku
proteins are related to acinar cell death, -D-glucose (10 mM) and GO (5
milliunits/ml) were added to the acinar cells. The wild-type cells and the
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cells transfected with either the control pcDNA3 vector (pcN-3) or the
C-terminal Ku80 (427–732) expression gene (KuD/N) or the cells trans-
fected with either the Ku70 or Ku80 expression gene (Ku70 or Ku80)
were used. The Ku-DNA binding activity and Western blotting for Ku70
and Ku80 were used to determine the functional efficiency and the
transfection efficiency, respectively. The cells were incubated at 37 °C
for 12 h for Western blotting for Ku70 and Ku80 in the whole cell
extracts, the cytoplasmic extracts, and the nuclear extracts (see Fig. 6),
as well as the Ku-DNA binding activity (see Fig. 7).
To determine the extent of cell viability and apoptosis, the cells were
treated with -D-glucose (10 mM) and GO (3 and 5 milliunits/ml) and
cultured for 24 h. The cell viability was determined directly by cell
counting (trypan blue exclusion test) and indirectly by testing for the
3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)-
positive cells. DNA fragmentation, as assessed by the content of nucleo-
some-bound DNA, was used as the apoptotic index (see Fig. 8).
For the concentration response of G/GO, the wild-type cells were
treated with -D-glucose (10 mM) and varied concentrations of GO (1, 5,
and 10 milliunits/ml) for 12 h (Western blotting for Ku70 and Ku80)
(see Fig. 3, A and B) and 24 h (cell viability and DNA fragmentation)
(see Fig. 1). For the time response of G/GO, the wild-type cells were
treated with -D-glucose (10 mM) and GO (5 milliunits/ml) for 4, 12, and
24 h to measure the cell viability (see Fig. 2A), and Western blotting
was used to determine the Ku70 and Ku80 levels in the whole cell
extracts, the cytoplasmic extracts, and the nuclear extracts (see Fig. 3,
A and C). As apoptotic indices, Western blotting for PARP cleavage,
p53, Bcl-2, and Bax was performed in the whole cell extracts after the
G/GO treatment for 4, 8, and 12 h (see Fig. 2B). To measure the amount
of H2O2 generated by G/GO, the wild-type cells were treated with GO (1,
5, and 10 milliunits/ml) and with -D-glucose (10 mM) for 12 and 24 h,
respectively, and the culture medium was analyzed for H2O2. The H2O2
generated by the G/GO in the medium was determined using the
method reported by Thurman et al. (43).
For one set of experiment, the wild-type cells were treated with or
without G/GO (5 milliunits/ml) and cultured in the presence (caspase-3
inhibitor) or absence (control) of the caspase-3 inhibitor (5 M; Z-
Asp(Ome)-Glu(Ome)-Val-Asp(Ome)-CH2F; Z-DEVD-fmk; Calbiochem,
San Diego, CA) for 12 h. The Ku70 and Ku80 expression levels were
determined by Western blotting (see Fig. 4A). Intracellular distribution
of Ku70 or Ku80 was determined with immunofluorescence staining of
Ku70 or Ku80 using fluorescein isothiocyanate-conjugated secondary
antibody (see Fig. 5). To determine the cell viability (MTT-positive
cells), the cells were treated with or without G/GO (3 and 5 milliunits/
ml) and cultured in the presence of the caspase-3 inhibitor for 24 h (see
Fig. 4B). All of the parameters were compared with those from the cells
treated without G/GO. The caspase-3 inhibitor was dissolved in di-
methyl sulfoxide. The final concentration of each vehicle was less than
0.1%. Each vehicle-treated cell was considered as the control. The drug
concentration used in the study was adapted from a previous study (44).
To determine the effect of G/GO on Ku synthesis and degradation,
the wild-type cells were pulsed or pulse-chased with [35S]methionine
with or without treatment of G/GO (5 milliunits/ml) and immunopre-
cipitated with anti-Ku70 or anti-Ku80 antibodies. The levels of Ku70
and Ku80 were determined in the whole cell extracts at 4 and 12 h or
culture and in the cytoplasmic extracts and the nuclear extracts at 12 h
of culture (see Figs. 9–12).
To determine the nuclear import of Ku proteins, an in vitro binding
assay using GST or GST-importin  fusion protein was performed in the
wild-type cells treated with or without G/GO (3 and 5 milliunits/ml) for
12 h. Bound protein levels were determined by Western blotting for
Ku70, Ku80, and importin . The importin  level was monitored in the
wild-type cells treated with or without G/GO (3 and 5 milliunits/ml) for
12 h (see Fig. 13).
Preparation of Extracts—The wild-type cells were treated with or
without G/GO (5 milliunits/ml) and cultured in the presence or absence
of the caspase-3 inhibitor. In other experiments, the transfected cells
(pcN-3, Ku D/N, Ku70, and Ku80 cells) were treated with or without
G/GO (5 milliunits/ml) for 12 h. The cells were harvested with trypsin,
washed with ice-cold phosphate-buffered saline (PBS) and lysed by
adding a SDS solubilization buffer (125 mM Tris-HCl, pH 7.5, 5 mM
EDTA, and 1% SDS). The lysates were then boiled for 5 min and
centrifuged at 15,000  g for 20 min. The supernatants were collected
and used as the whole cell extracts. To prepare the cytoplasmic and
nuclear extracts, the cells were harvested with trypsin, resuspended in
100 l of the hypotonic buffer (10 mM Hepes, pH 7.9, 10 mM KCl, 1.5 mM
MgCl2, 0.5% Nonidet P-40, 0.5 mM dithiothreitol (DTT), and 0.5 mM
phenylmethylsulfonyl fluoride), and placed on ice for 20 min. The ex-
tracts were centrifuged at 15,000  g for 20 min at 4 °C. The superna-
tants were collected as the cytoplasmic extracts. The pellets were
washed once with a hypotonic buffer, resuspended in 50 l of the
extraction buffer (20 mM Hepes, pH 7.9, 420 mM NaCl, 0.5 mM EDTA,
1.5 mM MgCl2, 25% glycerol, 0.5 mM DTT, and 0.5 mM phenylmethyl-
sulfonyl fluoride) and placed on ice for 20 min. The extracts were
centrifuged at 15,000 g for 20 min at 4 °C, and the supernatants were
used as the nuclear extracts (45). The protein concentration was deter-
mined using the method reported by Bradford (46).
Western Blot Analysis—The whole cell extracts (50 g of protein/
lane), the cytoplasmic extracts (50 g of protein/lane), and the nuclear
extracts (25 g of protein/lane) were loaded, separated by 8% SDS-
polyacrylamide gel electrophoresis under reducing conditions, and
transferred onto nitrocellulose membranes (Amersham Biosciences) by
electroblotting. The transfer of the protein and the equality of the
loading in the lanes was verified using reversible staining with Ponceau
S. The membranes were blocked with 5% nonfat dry milk in TBS-T
(Tris-buffered saline and 0.15% Tween 20) for 3 h at room temperature.
The proteins were detected with polyclonal antibodies for Ku70 (1:1000;
sc-1487), Ku80 (1:500; sc-1484), actin (1:1000; sc-1615), aldolase (1:500;
sc-12059), and histone H1 (1;500; sc-8615) (all from Santa Cruz Bio-
technology, Santa Cruz, CA) diluted in TBS-T containing 5% dry milk
and incubated at 4 °C overnight. After washing in TBS-T, the immu-
noreactive proteins were visualized using goat anti-rabbit secondary
antibodies conjugated to horseradish peroxidase, which was followed by
enhanced chemiluminescence (Amersham Biosciences). To detect PARP
cleavage, the rabbit polyclonal antibody for PARP (1:1000) (Santa Cruz
Biotechnology, sc-7150) was used as the primary antibody. Western
blotting for p53, Bcl-2, Bax, importin , and actin were performed using
mouse monoclonal antibody for p53 (1:200) (ParMingen/Beckton Dick-
inson Co., San Diego, CA; 554157), mouse monoclonal antibody for Bcl-2
(1:500) (Transduction Laboratories, San Diego, CA; 610538), mouse
monoclonal antibody for Bax (1:500) (Transduction Laboratories, San
Diego, CA; 610983), mouse monoclonal antibody for importin  (1:2000)
(Alexis Biochemicals, San Diego, CA; NTF97), and polyclonal antibody
for actin (1:1000) (Santa Cruz Biotechnology; sc-1615) as the primary
antibodies, respectively. Actin was used for the protein loading control,
whereas aldolase A and histone H1 were used for the cytoplasmic and
nuclear controls, respectively. Exactly equal amounts of protein, deter-
mined by Bradford method (46), were loaded in each lane. The Western
result presented in each figure is the representative of five separate
experiments.
Electrophoretic Mobility Shift Assay—Electrophoretic mobility shift
assay was carried out by a slight modification of the method reported by
Li et al. (47). The nuclear extracts (2 g of nuclear protein) of wild-type,
pcN-3, and KuD/N cells were incubated with the 32P-labeled double-
stranded oligonucleotide, 5-GGGCCAAGAATCTTAGCAGTTTCGGG-
3, in a buffer containing 12% glycerol, 12 mM Hepes, pH 7.9, 1 mM
EDTA, 1 mM DTT, 25 mM KCl, 5 mM MgCl2, and 0.04 g/ml poly(dI-dC)
at room temperature for 30 min. The reaction mixtures were subjected
to electrophoretic separation at room temperature on a nondenaturing
5% acrylamide gel at 30 mA using 0.5 Tris-borate-EDTA buffer. The
gels were dried at 80 °C for 1 h and exposed to the radiography film for
6–18 h at 70 °C with intensifying screens.
Cell Counting and MTT Assay—Cell viability was determined di-
rectly by counting with hemocytometer by a trypan blue exclusion test
(0.2% trypan blue) and indirectly by a colorimetric immunoassay (MTT
assay). For the trypan blue exclusion test, the cells were plated at 2 
104 cells/well in a 24-well culture plate and then incubated for 24 h. The
number of cells was counted with a hemocytometer using 0.2% trypan
blue. For the MTT assay, the cells (1.5 104 cells/well) were plated onto
a 96-well culture plate and cultured for 24 h. MTT (2.5 mg/ml) was
added, and the reaction mixture was incubated at 37 °C for 4 h. Cellular
formazan was extracted with acidic propan-2-ol, and the absorbance
was measured using a dual wavelength automatic plate reader at 570
nm/630 nm (48). Viable cells were expressed as the MTT-positive cells.
The MTT-positive cells shown in the wild-type cells or the pcN-3 cells
treated without G/GO (Wild for Figs. 1B and 4B and pcN-3 for Fig. 8B)
was considered to be 100%. The relative MTT-positive cells are ex-
pressed as a percentage of the value.
Quantitation of DNA Fragmentation—The nucleosomes were quan-
tified using a sandwich enzyme-linked immunosorbent assay (Cell
Death Detection ELISAplus kit; Roche Molecular Biochemicals GmbH,
Germany). In brief, the wild-type cells (5  104 cells/well) were treated
with various GO concentrations (1, 3, 5, and 10 milliunits) with 10 mM
glucose for 24 h (see Fig. 1C). The transfected cells (pcN-3, KuD/N,
Ku70, and Ku80 cells) were treated with 3 milliunits of GO using 10
mM glucose and cultured for 24 h (see Fig. 8C). The cells were detached,
and 1  105 cells were lysed. After cell lysis, the nucleosome-bound
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DNA was quantified using biotin-coupled mouse monoclonal anti-his-
tone antibody as the capturing antibody, peroxidase-conjugated mouse
monoclonal anti-DNA antibody as the detecting antibody, and 2,2-azio-
di[3-ethylbenhioazolin-sulfonate as a developing reagent. The relative
increase in the number of nucleosomes in the cell lysate, determined at
405 nm, was expressed as an enrichment factor. The enrichment factor
of the wild-type cells or the pcN-3 cells treated without G/GO was
considered to be 1 (Wild for Fig. 1C and pcN-3 for Fig. 8C).
Immunofluorescence Staining—The wild-type cells (5  104 cells/
well) were grown on Lab-Tek chamber slides (Nunc Inc., Naperville, IL)
overnight and treated with or without G/GO (5 milliunits/ml) in the
presence (caspase-3 inhibitor) or absence (control) of the caspase-3
inhibitor (5 M; Z-Asp(Ome)-Glu(Ome)-Val-Asp(Ome)-CH2F; Z-DEVD-
fmk, Calbiochem) for 12 h. The cells were washed with PBS, air-dried,
and fixed in cold 100% methanol for 10 min at room temperature (49).
The fixed cells were first blocked for 30 min in a blocking solution (5%
goat serum, 1% bovine serum albumin, and 0.1% gelatin in PBS con-
taining 0.001% sodium azide) and then incubated for 60 min at room
temperature with polyclonal antibody for Ku70 (1:200) (Santa Cruz
Biotechnology; sc-1487) or Ku80 (1:200) (Santa Cruz Biotechnology;
sc-1484) diluted in blocking solution. After washing with PBS, antibody
binding was detected by the application of fluorescein isothiocyanate
(Cappel Laboratories, Durham, NC)-conjugated secondary antibody
(anti-goat IgG antibody) dilated at a 1:100 dilution with blocking solu-
tion for 60 min. The cells were covered with the antifade medium
Vectashield (Vector Laboratories, Burlingame, CA) containing 4,6-
diamidino-2-phenylindole (DAPI) (0.25 g/ml end concentration) follow-
ing two more washes in PBS and a postfixation step with 3.7%
paraformaldehyde for 5 min. The preparations were stored for at least
1 h to allow saturation with DAPI to specifically stain the nucleus.
Immunofluorescence images for Ku proteins and the images of the
nucleus stained with DAPI were obtained using a Zeiss LSM510 con-
focal microscope (see Fig. 5).
[35S]Methionine Experiment—For the pulse experiment, the wild-
type cells (5  106 cells/well) were treated with or without G/GO (5
milliunits/ml) and pulsed with [35S]methionine (final concentration,
100 Ci/ml) (Amersham Biosciences) during the last 4 h of each incu-
bation. Briefly, the cells were treated with or without G/GO for either 4
or 12 h. [35S]Methionine was added to the cells at the start of the
incubation (4 h of treatment) or after 8 h of culturing with G/GO (12 h
of treatment). Thus, the pulsed cells were cultured for 4 h. During
pulsing with [35S]methionine, the cells were cultured in methionine-
and cysteine-free DMEM containing the dialyzed 10% fetal bovine
serum. For the pulse-chase experiment, the wild-type cells (5  106
cells/well) were preincubated in methionine- and cysteine-free DMEM
containing the dialyzed 10% fetal bovine serum and [35S]methionine
(final concentration, 100 Ci/ml) for 4 h. The cells were then washed
with complete DMEM and cultured for 4 and 12 h with or without the
G/GO treatment (5 milliunits/ml). At each time point, the cells were
lysed in a radioimmunoprecipitation buffer (10 mM Tris, pH 7.4, 1.0%
Nonidet P-40, 0.15 M NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% sodium
deoxycholate, and 0.5 mM phenylmethylsulfonyl fluoride) (50, 51). The
cytoplasmic extracts and the nuclear extracts from the cells were pre-
pared as described above. Either the whole cell extracts (100 g of
protein), the cytoplasmic extracts (100 g of protein), or the nuclear
extracts (50 g of protein) were immunoprecipitated with the anti-Ku70
or anti-Ku80 antibodies (final concentration, 5 g/ml), collected by
protein G-agarose beads (Sigma) at 4 °C, resolved by SDS-PAGE, and
then visualized by autoradiography. The density shown in the cells
treated without G/GO at 0 h (see Figs. 9 and 11) or at 12 h (see Figs. 10
and 12) was considered to be 100%. The relative densities were ex-
pressed as a percentage of that value at either 0 h (see Figs. 9 and 11)
or 12 h (see Figs. 10 and 12).
In Vitro Binding Assay—Bacteria transformed with plasmids encod-
ing GST and GST-importin- fusion protein were cultured overnight at
37 °C, then isopropyl -D-thiogalactopyranoside (0.5 mM) was added,
and incubation was continued for another 3 h to induce protein expres-
sion. The bacteria were collected by centrifugation and were resus-
pended in STE buffer (10 mM Tris, pH 8.0, 150 mM NaCl, and protease
inhibitors). The bacteria were lysed by incubation with 0.1 mg/ml ly-
sozyme at 4 °C for 15 min, followed by the addition of 5 mM DTT and
1.5% N-laurylsarcosyl (sarkosyl) to recover GST and GST-importin-.
The bacteria were disrupted by brief sonication on ice, and the lysates
were clarified by centrifugation at 10,000  g for 15 min. Each super-
natant was incubated at 4 °C for 1 h with 200 l of glutathionine-
agarose bead (Sigma). The agarose bead was collected and washed four
times with STE buffer. GST and GST-importin- fusion protein were
eluted from the glutathione-agarose bead as described (52), and free
glutathione was removed using Sephadex G-50 column. The wild-type
cells treated with or without G/GO (3, 5 milliunits/ml) for 12 h were
lysed in the lysis buffer containing 50 mM Tris, pH 7.4, 100 mM NaCl, 2
mM MgCl2, 1 mM DTT, 1% Nonidet P-40, 10% glycerol, and protease
inhibitors. The cleared lysates (200 g) were incubated overnight with
10 g of GST or GST-importin- bound to glutathionine-agarose beads
at 4 °C. The agarose beads were collected and washed four times with
lysis buffer. The bound proteins were released by boiling for 5 min with
50 l of SDS sample buffer and detected by SDS-PAGE and Western
blot analysis using anti-Ku70, anti-Ku80, and anti-importin  antibod-
ies (see Fig. 13A).
Statistical Analysis—The results are expressed as the means  S.E.
of five separate experiments. The analysis of the variance followed by
the Newman-Keul’s test was used for statistical analysis (53). p  0.05
was considered statistically significant.
RESULTS
Concentration and Time Responses of G/GO for H2O2 Pro-
duction and the Apoptotic Indices (Cell Viability, DNA Frag-
mentation, PARP Cleavage, and Expression Changes of p53,
Bcl-2, and Bax) in AR42J Cells—Because the susceptibility of
the cells to G/GO-mediated damage varies among the different
cell types, the cell strains, and passage numbers within the
same strain (54–56), the concentration and time responses of
G/GO to the wild-type AR42J cells were determined. The H2O2
content in the medium released from the cells were 0.85  0.04
nmol/ml at 12 h and 7.31  1.59 nmol/ml at 24 h, respectively.
The cells treated with -D-glucose (10 mM) and various GO (1,
5, and 10 milliunits/ml) concentrations released H2O2 into the
medium in amounts of 2.84  1.12, 17.11  2.09, and 32.08 
1.61 nmol/ml at 12 h and 30.17  5.02, 64.03  8.10, and
115.16  7.31 nmol/ml at 24 h. To determine the relationship
between the oxidative stress and apoptosis, the concentration
response of G/GO (1, 5, and 10 milliunits/ml) for the cell via-
bility and the nucleosome-bound DNA was determined in the
cells after the 24-h treatment with G/GO. At 24 h, the number
of viable cells, determined by trypan blue exclusion test (Fig.
1A) and MTT assay (Fig. 1B), was significantly lower at GO 5
and 10 milliunits/ml, which was in parallel with the increases
in the nucleosome-bound DNA, an index of DNA fragmentation
(Fig. 1C). For the time response of G/GO, the cells treated with
G/GO (5 milliunits/ml) were cultured for 4, 12, and 24 h, and
the viable cells were counted with a trypan blue exclusion test.
At a GO concentration of 5 milliunits/ml, the number of viable
cells was lower at 12 and 24 h (Fig. 2A). The number of viable
cells (104 cells/ml) from the cells treated with G/GO were
7.70  0.23, 7.31  0.28, 4.11  0.29, and 2.41  0.21 at the
start of the experiment and at 4, 12, and 24 h of culture,
respectively (Fig. 2A). Western blotting analysis for p53, Bax,
and Bcl-2 showed a significant induction of p53 and Bax ac-
companied with a loss of Bcl-2 in the wild-type cells treated
with G/GO (5 milliunits/ml) for 12 h. PARP cleavage to the
85-kDa peptides was detected at 8 and 12 h.
Concentration and Time Responses of G/GO for Ku Expres-
sion in AR42J Cells—To monitor the changes in Ku70 and
Ku80 during G/GO-induced apoptosis, the concentration and
time responses of G/GO for Ku expression were determined at
12 h. Both Ku70 and Ku80 levels in the whole cell extracts were
unaltered by the G/GO treatment (Fig. 3A). Even high G/GO
(10 milliunits/ml) concentration for 24 h did not affect the total
levels of both Ku70 and Ku80. However, the nuclear Ku70 and
Ku80 levels were drastically lowered with increasing GO con-
centrations and culture time (Fig. 3, B and C). The decreases in
the nuclear Ku70 and Ku80 were evident at GO 5 milliunits/ml
for a 12-h culture. The nuclear Ku70 level was almost lost at
GO 5 milliunits/ml for 12 h (Fig. 3B), whereas the nuclear Ku80
almost disappeared at GO 5 milliunits/ml for 12 h (Fig. 3C).
The loss of nuclear Ku70 and Ku80 were more evident at GO 10
milliunits/ml for a 24-h culture. Interestingly, cytoplasmic
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Ku80 tended to be increased by G/GO in a concentration- and
time-dependent manner, whereas cytoplasmic Ku70 was
slightly affected by the G/GO treatment.
Effect of Caspase-3 Inhibitor on Ku Expression, Cell Viabil-
ity, and Intracellular Distribution of Ku in AR42J Cells Treated
with or without G/GO—The wild-type cells were treated with
G/GO (GO 5 milliunits/ml) in the presence or absence (control)
of the caspase-3 inhibitor for 12 h. Western blot results showed
that G/GO induced significant decreases in the nuclear Ku70
and Ku80 levels, which was prevented by treatment with the
caspase-3 inhibitor (Fig. 4A). The cytoplasmic Ku70 levels were
slightly altered by G/GO, whereas the cytoplasmic Ku80 levels
were increased by G/GO. Treatment with caspase-3 inhibit7or
had no effect on these changes in the cytoplasmic Ku70 and
Ku80. G/GO induced cell death in a concentration-dependent
manner, as determined by the number of the MTT-positive
cells (Fig. 4B). The number of MTT-positive cells shown in the
wild-type cells treated with G/GO (None) was considered to be
100%. The relative number of MTT-positive cells in the cells
treated with G/GO at 3 and 5 milliunits/ml were 58.79  2.97
and 28.75  3.03, respectively, in the absence of the caspase-3
inhibitor, whereas those cultured in the presence of the
caspase-3 inhibitor were 90.06 4.39 and 74.90 8.09, respec-
tively. Caspase-3 inhibitor prevented G/GO-induced cell death,
suggesting the involvement of capase-3 activation in oxidative
stress-induced apoptosis.
Intracellular distribution of Ku70 and Ku80 of the wild-type
cells was determined by immunofluorescence staining of Ku
proteins using fluorescein isothiocyanate-conjugated secondary
antibody. Because pancreatic acinar cells were grown as acinus
formation as reported previously (57, 58), one representative
acinus was visualized. Immunofluorescence staining revealed
that Ku70 and Ku80 were abundant both in the cytoplasm and
the nucleus in the wild-type cells treated without G/GO in the
absence of the caspase-3 inhibitor (Fig. 5A). Treatment of the
caspase-3 inhibitor has no effect on intracellular distribution of
Ku70 and Ku80 in the wild-type cells treated without G/GO
(Fig. 5B). However, G/GO treatment in the absence of the
FIG. 1. Concentration response of G/GO for cell viability and
DNA fragmentation in AR42J cells. The wild-type cells were treated
with -D-glucose (10 mM) and varying GO concentrations (1, 5, and 10
milliunits/ml) for 24 h. The cell viability was determined directly by
trypan blue exclusion test (A) and indirectly by MTT assay (B). The
MTT-positive cells shown in the cells treated without G/GO (None) were
considered to be 100%. The relative MTT-positive cells were expressed
as percentages of that value. Enzyme-linked immunosorbent assay was
used to assess the extent of DNA fragmentation as the content of
nucleosome-bound DNA (C). The relative increase in the number of
nucleosomes in the cell lysate, determined at 405 nm, was expressed as
an enrichment factor. The enrichment factor of the cells treated without
G/GO (None) was considered to be 1. Each bar represents the mean 
S.E. of five separate experiments. *, p  0.05 versus the cells treated
without G/GO (None). G/GO, the cells treated with G/GO; bar 1, 1
milliunit/ml; bar 3, 3 milliunits/ml; bar 5, 5 milliunits/ml; bar 10,
10 milliunits/ml.
FIG. 2. Time responses of G/GO for cell viability, PARP cleav-
age, and expression changes of p53, Bcl-2, and Bax in AR42J
cells. For the time response of G/GO, the wild-type cells were treated
with -D-glucose (10 mM) and GO (5 milliunits/ml) for 12 h (PARP
cleavage, p53, Bcl-2, and Bax) or 24 h (cell viability). The viable cell
numbers were determined by trypan blue exclusion test (A). Each bar
represents the mean  S.E. of five separate experiments. *, p  0.05
versus 0 h. Western blotting for PARP and its cleavage product as well
as p53, Bcl-2, and Bax were used as the apoptotic indices (B). Actin was
used for the protein loading control. The Western result in each lane is
the representative of five separate experiments.
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caspase-3 inhibitor resulted in the nuclear loss of both Ku70
and Ku80, shown as undetectable fluorescence staining in the
nucleus, determined by DAPI counterstaining of the nucleus
(Fig. 5A). AR42J cells have relatively large nuclei as previous
immunofluorescence staining reported (57). The caspase-3 in-
hibitor prevented G/GO-induced nuclear loss of Ku70 and Ku80
in the wild-type cells (Fig. 5B). This is in agreement with
Western results of Ku70 and Ku80 expression levels shown in
Fig. 4A.
Effect of G/GO on Expression or DNA Binding Activity of Ku
in AR42J Cells and the Transfected Cells (pcN-3, KuD/N,
Ku70, and Ku80 Cells)—In the wild-type and pcN-3 cells,
12 h of treatment with G/GO induced slight changes in the
cytoplasmic Ku70 and Ku80 levels and significant decreases in
the nuclear Ku70 and Ku80 levels, respectively (Fig. 6). In the
Ku70 cells and Ku80 cells, the cytoplasmic Ku70 and Ku80
levels were higher in both cells treated with and without G/GO
compared with those in the wild-type and pcN-3 cells. The
G/GO-induced decrease in the nuclear Ku70 and Ku80 levels
were prevented in both Ku70 and Ku80 cells. However, the
prevention against the G/GO-induced loss of nuclear Ku70 and
Ku80 were more evident in the Ku80 cells. This result dem-
onstrates that both Ku70 and Ku80 contribute to the stability
of the other Ku subunits. G/GO resulted in a loss of the Ku-
DNA binding activity in the wild-type and pcN-3 cells. The loss
of the Ku-DNA binding activity was observed in the Ku D/N
cells even without G/GO (Fig. 7).
Effect of G/GO on Cell Viability and DNA Fragmentation in
AR42J Cells and the Transfected Cells (pcN-3, KuD/N, Ku70,
and Ku80 Cells)—In the wild-type and pcN-3 cells, 24 h of
treatment with G/GO (3 and 5 milliunits/ml) decreased the
number of viable cells, as determined directly by the trypan
blue dye exclusion test (Fig. 8A) and indirectly by MTT assay
(Fig. 8B), as well as the extent of DNA fragmentation deter-
mined by the nucleosome-bound DNA (Fig. 8C). The decrease
in cell viability (the viable cell number and MTT-positive cells)
and the increase in DNA fragmentation induced by G/GO treat-
ment were inhibited in the Ku70 and Ku80 cells. The G/GO-
induced cell death and apoptotic DNA fragmentation was ac-
celerated in the KuD/N cells. The relative increase in the
number of nucleosomes in the cell lysate was expressed as an
FIG. 3. Concentration and time responses of G/GO for Ku ex-
pression in AR42J cells. For the concentration response of G/GO, the
wild-type cells were treated with -D-glucose (10 mM) and varying GO
concentrations (1, 5, and 10 milliunits/ml) for 12 h. For the time re-
sponse of G/GO, the wild-type cells were treated with -D-glucose (10
mM) and GO (5 milliunits/ml) for 4, 12, and 24 h. Ku expression was
determined by Western blotting for Ku70 and Ku80 in the whole cell
extracts (A), the cytoplasmic extracts, and the nuclear extracts (B and
C). Actin was used for the protein loading control (A). Aldolase and
histone H1 were used as the cytoplasmic and nuclear controls, respec-
tively (B and C). Exactly equal amounts of protein were loaded in each
lane. The Western result in each lane is the representative of five
separate experiments. None, cells treated without G/GO; G/GO, cells
treated with G/GO; lane 1, 1 milliunit/ml; lane 5, 5 milliunits/ml; lane
10, 10 milliunits/ml.
FIG. 4. Effect of caspase-3 inhibitor on Ku expression and cell
viability of AR42J cells treated with or without G/GO. The wild-
type cells were treated with G/GO (5 milliunits/ml) in the presence or
absence of the caspase-3 inhibitor (5 M; Z-DEVD-fmk) for 12 h. West-
ern blot analysis was performed to analyze Ku70 and Ku80 in the
cytoplasmic and nuclear extracts (A). Aldolase and histone H1 were
used as the cytoplasmic and nuclear controls, respectively. Exactly
equal amount of protein was loaded in each lane. The Western result in
each lane is the representative of five separate experiments. The cell
viability was determined by the number of the MTT-positive cells (B).
The number of the MTT-positive cells shown in the cells treated without
G/GO (None) was considered to be 100%. The relative MTT-positive
cells were expressed as percentages of this value. Each bar represents
the mean  S.E. of five separate experiments. *, p  0.05 versus the
corresponding control. Control, cells treated with a vehicle (dimethyl
sulfoxide); Caspase-3 inhibitor, cells treated with caspase-3 inhibitor;
None, cells treated without G/GO; G/GO, cells treated with G/GO; bar 3,
3 milliunits/ml; bar 5, 5 milliunits/ml).
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enrichment factor for DNA fragmentation. Without the G/GO
treatment, the extent of DNA fragmentation was not changed
in the wild-type cells (1.00  0.08) and the transfected cells
(1.00  0.06). The amount of DNA fragmentation was changed
to 4.71 0.02, 5.22 0.18, 2.90 0.09, 2.91 0.26, and 6.52
0.08 in the wild-type, the pcN-3, the Ku70, the Ku80, and
the KuD/N cells after treatment with G/GO (3 milliunits/ml),
respectively (Fig. 8C). This result suggests that Ku70 and Ku80
overexpression prevent cell death and that the loss of the Ku
proteins induces apoptotic cell death.
Effect of G/GO on Synthesis and Degradation of Ku in
AR42J Cells—To determine the mechanism of the G/GO-in-
duced changes in Ku expression in the whole cell extracts, the
cytoplasmic extracts, and the nuclear extracts, the wild-type
cells were pulsed or pulse-chased with [35S]methionine with or
without the G/GO treatment for either 4 or 12 h. For the pulse
experiment, the cells were treated with or without G/GO and
pulsed with [35S]methionine during the last 4 h of each incu-
bation (Figs. 9 and 10). The syntheses of both Ku70 and Ku80,
as determined by the [35S]methionine pulse, were significantly
increased by G/GO in the whole cell extracts when compared
with the cells without the G/GO treatment at 4 and 12 h of
incubation. The density of [35S]methionine-Ku80 or [35S]methi-
onine-Ku70 shown in the cells treated without G/GO at 0 h was
considered to be 100%. The relative densities of [35S]methi-
onine-Ku80 in the cells treated without G/GO were 109.5 
FIG. 5. Intracellular distribution of Ku70 and Ku80 in AR42J
cells treated with or without G/GO in the presence or absence of
the caspase-3 inhibitor. The wild-type cells were treated with or
without G/GO (5 milliunits/ml) in the presence or absence of the
caspase-3 inhibitor (5 M, Z-DEVD-fmk) for 12 h. The cells were immu-
nostained with polyclonal antibody for Ku70 (left panels) and Ku80
(right panels). The immunoreactive proteins were visualized using flu-
orescein isothiocyanate-conjugated anti-goat IgG antibody (green, up-
per panels) with DAPI counterstaining (blue, lower panels) of the same
field containing one acinus. Intracellular distribution of Ku70 and Ku80
and the nucleus of the cells were observed by Zeiss LSM510 confocal
microscope. Loss of Ku proteins in the nucleus of the cells treated with
G/GO in the absence of the caspase-3 inhibitor (Control, G/GO), show-
ing undetectable fluorescence staining, determined by DAPI counter-
staining of the nucleus. The result is the representative of five separate
experiments. Control, cells cultured in the absence of the caspase-3
inhibitor (A); Caspase-3 inhibitor, cells cultured in the presence of the
caspase-3 inhibitor (B); None, cells treated without G/GO; G/GO, cells
treated with G/GO.
FIG. 6. Effect of G/GO on Ku expression in AR42J cells and the
transfected cells (pcN-3, Ku70, and Ku80 cells). The wild-type,
pcN-3, Ku70, and Ku80 cells were treated with or without G/GO (5
milliunits/ml) for 12 h. Ku expression was determined by Western
blotting for Ku70 and Ku80 in the cytoplasmic (A) and nuclear extracts
(B). Aldolase and histone H1 were used as the cytoplasmic and nuclear
controls, respectively. Exactly equal amounts of protein were loaded in
each lane. The Western result in each lane is the representative of five
separate experiments. Wild, nontransfected cells; pcN-3, cells trans-
fected with the control pcDNA3 vector; Ku70, cells transfected with
the Ku70 expression gene; Ku80, cells transfected with the Ku80
expression gene; None, cells treated without G/GO; G/GO, cells treated
with G/GO.
FIG. 7. Ku-DNA binding activity in the nuclear extract of
AR42J cells and the transfected cells (pcN-3 and KuD/N cells).
The wild-type, pcN-3, and KuD/N cells were treated with or without
G/GO (5 milliunits/ml) for 12 h. The Ku-DNA binding activity was
determined using 2 g of the nuclear protein by electrophoretic mobility
shift assay. The result is the representative of five separate experi-
ments. Wild, nontransfected cells; pcN-3, cells transfected with the
control pcDNA3 vector; KuD/N, cells transfected with the Ku dominant
negative mutant; None, cells treated without G/GO; G/GO, cells treated
with G/GO.
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2.11 and 86.82  1.51, and those treated with G/GO were
129.81  2.01 and 114.70  1.21 at 4 and 12 h of culture,
respectively. The relative densities of [35S]methionine-Ku70 in
the cells treated without G/GO were 104.4  2.51 and 99.56 
2.00, and those treated with G/GO were 143.51  2.61 and
133.60  2.21 at 4 and 12 h of culture, respectively (Fig. 9).
However, the G/GO-induced increase in Ku70 and Ku80 syn-
thesis was only shown in the cytoplasmic extracts and not in
the nuclear extracts at 12 h of culture (Fig. 10). When the
densities of [35S]methionine-Ku80 and [35S]methionine-Ku70
in the cells treated without G/GO were considered to be 100%,
[35S]methionine-Ku80 in the cells treated with G/GO were
147.98  2.90 in the cytoplasmic extracts and 96.31  1.01 in
the nuclear extracts. The relative densities of [35S]methionine-
Ku70 in the cells treated with G/GO were 148.84  2.89 in the
cytoplasmic extracts and 89.68  1.00 in the nuclear extracts.
For the pulse-chase experiment, the cells were preincubated
with [35S]methionine for 4 h and then cultured for 4 and 12 h
with or without the G/GO treatment. At each time point, the
amount of Ku expression was determined in the whole cell
extracts (Fig. 11), the cytoplasmic extracts, and the nuclear
extracts (Fig. 12). The Ku70 and Ku80 expression levels were
decreased by G/GO in the whole cell extracts when compared
with the cells without G/GO treatment at 4 and 12 h of culture.
The relative densities of [35S]methionine-Ku80 in the cells
treated without G/GO were 95.22  2.01 and 83.32  2.01, and
those treated with G/GO were 71.42 2.10 and 53.02 1.15 at
4 and 12 h, respectively. The relative densities of [35S]methi-
onine-Ku70 in the cells treated without G/GO were 93.31 
2.21 and 84.42  2.03, and those treated with G/GO were
75.51  2.31 and 66.60  2.01 at 4 and 12 h, respectively. At
12 h of culture, G/GO decreased the Ku70 and Ku80 expression
levels both in the cytoplasmic extracts and the nuclear extracts
(Fig. 12). When the densities of [35S]methionine-Ku80 and
[35S]methionine-Ku70 in the cells treated without G/GO were
considered to be 100%, the amounts of [35S]methionine-Ku80 in
the cells treated with G/GO were 78.22  1.99 in the cytoplas-
mic extracts and 59.70  1.21 in the nuclear extracts at 12 h of
culture. The relative densities of [35S]methionine-Ku70 in the
cells treated with G/GO were 79.32  1.89 in the cytoplasmic
FIG. 8. Effect of G/GO on cell viability and DNA fragmentation
in AR42J cells and the transfected cells (pcN-3, KuD/N, Ku70,
and Ku80 cells). The wild-type cells and the transfected cells (pcN-3,
KuD/N, Ku70, and Ku80 cells) were treated with or without G/GO (3
and 5 milliunits/ml) for 24 h. Cell viability was determined directly by
trypan blue exclusion test (A) and indirectly by MTT assay (B). The
MTT-positive cells shown in pcN-3 cells were considered to be 100%.
The relative MTT-positive cells were expressed as percentages of the
pcN-3 cells. Enzyme-linked immunosorbent assay was used to assess
the extent of DNA fragmentation as the content of nucleosome-bound
DNA (C). The relative increase in nucleosomes in the cell lysate, as
determined at 405 nm, was expressed as an enrichment factor. The
enrichment factor of the wild-type cells treated without G/GO (Wild,
None) was considered to be 1. Each bar represents the mean  S.E. of
five separate experiments. *, p  0.05 versus the corresponding pcN-3.
Wild, nontransfected cells; pcN-3, cells transfected with the control
pcDNA3 vector; Ku70, cells transfected with the Ku70 expression
gene; Ku80, cells transfected with the Ku80 expression gene; KuD/N,
cells transfected with the Ku dominant negative mutant; None, cells
treated without G/GO. GO 3mU, cells treated with 3 milliunits G/GO/
ml); GO 5mU, cells treated with 5 milliunits of G/GO/ml).
FIG. 9. Effect of G/GO on Ku synthesis in AR42J cells. For the
pulse experiment, the wild-type cells were treated with or without
G/GO and pulsed with [35S]methionine during the last 4 h of each
incubation. The density shown in the cells treated without G/GO (None)
at 0 h was considered to be 100%. The relative densities are expressed
as percentages of this value at 0 h. Each bar represents the mean S.E.
of five separate experiments. *, p  0.05 versus corresponding to the
untreated value at each time point (4 or 12 h). None, cells treated
without G/GO; G/GO, the cells treated with G/GO (5 milliunits/ml);
[35S]-Ku80, [35S]methionine-Ku80; [35S]-Ku70, [35S]methionine-Ku70.
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extracts and 76.08  1.01 in the nuclear extracts at 12 h
of culture.
Effect of G/GO on Ku Binding to Importin  and Importin 
as Well as Importin  Level in the Whole Cell Extracts of
AR42J Cells—To monitor the changes in the binding of Ku70
and Ku80 to importin  and importin  during G/GO-induced
apoptosis, GST and GST-importin- fusion protein were used.
Bound proteins to GST-importin- fusion protein in the whole
cell extracts were detected by Western blot analysis using
anti-Ku70, anti-Ku80, and anti-importin  antibodies. Both
Ku70 and Ku80 levels in the whole cell extracts were decreased
by the G/GO treatment dose-dependently, whereas importin 
was not affected by G/GO at 12 h (Fig. 13A). There was no
protein bound to GST. G/GO had no effect on protein level of
importin  in AR42J cells (Fig. 13B).
DISCUSSION
The relationship between ROS and apoptosis in the patho-
physiology of acute pancreatitis in acinar cells has been re-
FIG. 10. Effect of G/GO on Ku synthe-
sis in the cytoplasmic extracts and the
nuclear extracts of AR42J cells. For the
pulse experiment, the wild-type cells were
treated with or without G/GO and pulsed
with [35S]methionine during the last 4 h of
each incubation. The density of the cytoplas-
mic and nuclear extracts from the cells
treated without G/GO (None) at 12 h was
considered to be 100%. The relative densities
are expressed as percentages of this value at
12 h. Each bar represents the mean  S.E.
of five separate experiments. *, p  0.05
versus corresponding to the untreated value.
None, cells treated without G/GO; G/GO,
cells treated with G/GO (5 milliunits/ml);
[35S]-Ku80, [35S]methionine-Ku80; [35S]-
Ku70, [35S]methionine-Ku70.
FIG. 11. Effect of G/GO on Ku degradation in the whole cell ex-
tracts of AR42J cells. For the pulse-chase experiment, the wild-type cells
were preincubated with [35S]methionine for 4 h. The cells were then washed
with complete DMEM and cultured for 4 and 12 h with or without the G/GO
treatment. The density shown in the cells treated without G/GO (None) at
0 h was considered as 100%. The relative densities are expressed as per-
centages of this value at 0 h. Each bar represents the mean  S.E. of five
separate experiments. *, p  0.05 versus corresponding to the untreated
value at each time point (4 or 12 h). None, cells treated without G/GO; G/GO,
cells treated with G/GO (5 milliunits/ml); [35S]-Ku80, [35S]methionine-Ku80;
[35S]-Ku70, [35S]methionine-Ku70.
FIG. 12. Effect of G/GO on Ku degradation in the cytoplasmic
extracts and the nuclear extracts of AR42J cells. For the pulse-
chase experiment, the wild-type cells were preincubated with [35S]me-
thionine for 4 h. The cells were then washed with complete DMEM and
cultured for 12 h with or without the G/GO treatment. The density of
the cytoplasmic and nuclear extracts from the cells treated without
G/GO (None) at 12 h was considered to be 100%. The relative densities
are expressed as percentages of this value at 12 h. Each bar represents
the mean  S.E. of five separate experiments. *, p  0.05 versus
corresponding to the untreated value. None, cells treated without G/GO;
G/GO, cells treated with G/GO (5 milliunits/ml); [35S]-Ku80, [35S]me-
thionine-Ku80; [35S]-Ku70, [35S]methionine-Ku70.
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ported (19, 20). In cerulein-induced pancreatitis, a high degree
of ROS generation and apoptosis were observed in pancreatic
acinar cells (17, 56, 59). In 38 chronic pancreatitis patients, the
distribution of caspase-1 expression was correlated with the
extent of apoptosis of acinar cells in pancreatic tissues (61).
These studies indicated the possibility that the development of
apoptotic cell death caused by ROS may reflect the severity of
pancreatitis, which might have substantial clinical value. Elu-
cidating the molecular mechanisms of pancreatic cell death will
provide valuable insights into clinical pancreatic disorders and
may offer potential pharmacological interventions. The AR42J
cell line is the only currently available cell line that maintains
many characteristics of normal pancreatic acinar cells, such as
the synthesis and secretion of digestive enzymes (62). AR42J
cell receptor expression and signal transduction mechanisms
parallel those of pancreatic acinar cells (62). Thus, this cell line
has been widely used as an in vitro model to study cellular
secretion, growth, proliferation, and apoptosis of the exocrine
pancreas (57, 62–65).
In this study, oxidative stress-induced apoptosis was inves-
tigated to determine whether it is related to the low expression
level of Ku70 and/or Ku80 in AR42J cells, as determined by the
Ku expression level and intracellular distribution, the apo-
ptotic indices (quantification of DNA fragmentation, PARP
cleavage, increase in p53 and Bax expression, decrease in Bcl-2
expression), and the Ku-DNA binding activity. Continuous ox-
idative stress, generated by G/GO, induced apoptotic cell death,
which was mediated by low nuclear Ku70 and Ku80 in the cells.
Ku70 and Ku80 in the whole cell extracts were not changed by
the G/GO treatment. The cytoplasmic Ku80 tended to increase,
but the cytoplasmic Ku70 was slightly affected by G/GO. The
results clearly demonstrate the novel role of nuclear Ku70 and
Ku80 in preventing the apoptosis caused by oxidative stress.
The importance of nuclear Ku70 and Ku80 was confirmed by
the protection of cell death by the preservation of nuclear Ku70
and Ku80 in the cells transfected with the Ku70 or Ku80
expression gene (Ku70 and Ku80) and accelerated cell death
by the loss of the Ku-DNA binding activity in the cells trans-
fected with the Ku dominant negative mutant (KuD/N). G/GO-
induced decrease in Ku binding to importin  and importin 
reflects a possible modification of the nuclear import of Ku70
and Ku80. The importin  level was not changed by G/GO,
determined by in vitro binding assay using GST-importin 
fusion protein and Western blot analysis. These results clearly
demonstrated that G/GO did not affect the protein level of
nuclear transporter but do affect Ku binding to nuclear trans-
porter importins. G/GO-induced decrease in Ku binding to im-
portins, importin  and importin , and degradation of Ku70
and Ku80 may cause a loss of defense against oxidative DNA
damage, which underlies the mechanism of apoptosis in pan-
creatic acinar cells.
Oxidative damage to the nucleic acids can produce adducts of
the base and sugar residues, which may lead to the generation
of single-stranded breaks. Less frequently, oxidation can cause
cross-links to other molecules and double-stranded breaks (25).
Ischemia/reperfusion in the rabbit spinal cord induces revers-
ible neurological deficits with the increased Ku-DNA binding
activity, which is an indicator of DNA-PK activation, whereas
severe ischemia/reperfusion causes permanent deficits accom-
panied by the deceased Ku-DNA binding activity. This suggests
that Ku is involved in oxidative injury (26). Fujimura et al. (66,
67) recently have reported that a decrease in the DNA base
excision repair proteins, apurinic/apyrimidinioc endonuclease
and XRCC1, precedes the occurrence of DNA fragmentation
after focal cerebral ischemia. Therefore, it is assumed that Ku
may play a role in the cell death mechanisms, particularly DNA
fragmentation after oxidative stress, and that Ku reduction
may involve the mechanism of apoptotic cell death.
Several studies have shown that the inhibition of either
Ku70 or Ku80 expression resulted in the induction of apoptosis
in human promyelocytic leukemia HL-60 cells and activated
human peripheral blood lymphocytes (68), embryonic stem
cells and pre-B cells (69), and human HCT116 colon cancer
cells (70). In contrast, no loss of the Ku protein was noted in
the cells undergoing apoptosis by x-ray irradiation in human
glioma cells (71) and in Fas-mediated apoptosis in Jurkat cells
(72, 73). This is despite the fact that DNA-PK was cleaved by
the caspases during apoptosis in these cells. A DNA-PK defi-
ciency in the cultured neurons caused an accumulation of DNA
damage and increased susceptibility to caspase-independent
forms of apoptosis (74). Therefore, the exact mechanism by
which the selective reduction of Ku occurs during the apoptosis
is unclear. Furthermore, there is no consistent evidence as to
whether or not the Ku proteins are degraded in the cells under
oxidative stress.
There is some evidence suggesting the involvement of
caspase-3 activation in H2O2-induced apoptosis in HL-60 cells
(31, 32), cultured astrocytes (33), activated human peripheral
blood lymphocytes (34), hepatoblastoma HepG2 cells (35), and
human neuroblastoma cells (36). They suggested H2O2 as a
second messenger of the death signal in some diseases linked to
oxidative stress stimuli. Both cell death and PARP cleavage
were prevented either by the caspase-3 inhibitor (31, 34) or a
known antioxidant glutathione (35). In contrast, high concen-
trations of H2O2 (above 300 nmol/ml) suppressed both the
activation and the activity of the caspases, possibly by modu-
lating the redox status of the cells and the oxidation of the
cysteine residues in the caspases. They also showed that low
concentration of H2O2 (50 nmol/ml) induced apoptosis in Jur-
kat T-lymphocytes (75). The time points used in this study were
12 h for Ku expression and 24 h for apoptotic cell death. The
H2O2 produced in the cells treated with G/GO (5 milliunits/ml)
was 17.11 nmol/ml at 12 h and 64.03 nmol/ml at 24 h, respec-
tively. Therefore, the H2O2-induced apoptosis is supported by
these previous studies (31–36, 75). To determine the exact
FIG. 13. Effect of G/GO on Ku binding to importin  and im-
portin  as well as the importin  level in the whole cell extracts
of AR42J cells. To determine the nuclear import of Ku proteins, in
vitro binding assay using GST or GST-importin  fusion protein was
performed in the wild-type cells treated with or without G/GO (3 and 5
milliunits/ml) for 12 h. The bound protein levels were determined by
Western blotting for Ku70, Ku80, and importin  (A). The importin 
level was monitored in the wild-type cells treated with or without G/GO
(3 and 5 milliunits/ml) for 12 h (B). Actin was used for the protein
loading control. The Western result in each lane is the representative of
five separate experiments. None, cells treated without G/GO.
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mechanism responsible for the reduction in the nuclear Ku70
and Ku80 after oxidative stress, Ku expression was observed in
the cells treated with G/GO in either the presence or absence of
the caspase-3 inhibitor in this study. The reduction in nuclear
Ku proteins of the cells undergoing apoptosis was blocked by
the treatment with the caspase-3 inhibitor. The caspase-3 in-
hibitor prevented the loss of nuclear Ku70 and Ku80 in apo-
ptotic cells, determined by Ku expression level and intracellu-
lar distribution. These results suggest that the caspase cascade
during apoptosis may involve the degradation of Ku70 and
Ku80. Therefore, after oxidative stress, the reduction in Ku
might be involved in downstream from the caspase-activating
apoptotic pathway. There are studies on the subcellular local-
ization of Ku70 and Ku80 (40, 41, 76, 77) demonstrating that
the control mechanism for subcellular localization of Ku70 and
Ku80 plays a key role in regulating the physiological function
of Ku in vivo. Each Ku subunit can translocate to the nucleus
not only through its own NLS, but also through heterodimer-
ization with each other (78). The Ku70 NLS and the Ku80 NLS
are mediated to target to the nuclear rim by two components of
the nuclear pore-targeting complex, importin , and importin 
(40, 41). The active nuclear transporter, importin , has an
essential role for the nuclear transport of the apoptotic signal-
ing molecules including the caspases (79). Because Ku70 and
the caspases share the same nuclear transporter, Ku70 may be
cleaved by the caspases in the nucleus during apoptosis. This
possibility is supported by studies showing that activated
capase-3 was observed in the nucleus during apoptosis (80),
and both the DNA-PKcs and PARP are substrates for caspase-
3-like activities after ischemia/reperfusion (26). In addition, the
well known nucleoporins Nup153, RanBP2, Nup214, and Tpr,
which binds the soluble components of the nuclear transport
machinery such as the importin family and the small GTPase
Ran (81, 82), are cleaved by caspases during apoptosis (37).
Nucleoporin cleavage may affect the nucleocytoplasmic trans-
port in the cells during apoptosis, even though nuclear trans-
port factors, Ran, importin , and importin  are not proteo-
lytically processed (37). Endoh et al. (83) reported the
insignificant difference between the total protein levels of Ku70
and Ku80 by x-ray irradiation in rats even though the nuclear
translocation of Ku70 and Ku80 from the cytoplasm was inhib-
ited after x-ray irradiation. This led to the inhibition of the fast
repair process of DNA double-stranded breaks. The inhibition
of the nuclear translocation of the Ku proteins by oxidative
stress might be another possible explanation for the loss of
nuclear Ku70 and Ku80 and the slight increases in the cyto-
plasmic Ku proteins in AR42J cells undergoing apoptosis. The
results from the pulse experiment and the pulse-chase experi-
ment show that Ku synthesis is increased by oxidative stress,
which might result from the homeostasis of the cells because
the expressions of both Ku70 and Ku80 were decreased by the
G/GO treatment. Moreover, the G/GO-induced loss of Ku70 and
Ku80 were shown in both the cytoplasmic and nuclear extracts.
These results clearly demonstrate that even though Ku70 and
Ku80 were degraded by G/GO in the cytoplasm, the Ku protein
levels could be maintained by the newly synthesized Ku pro-
teins by G/GO. Because the Ku binding to the importin family
was decreased and nuclear Ku proteins were degraded by oxi-
dative stress in the present study, the significant loss of the
nuclear Ku proteins were shown in the cells exposed to oxida-
tive stress, resulting in the loss of defense against oxidative
DNA damage and apoptosis in pancreatic acinar cells.
In addition to degradation of Ku proteins by ROS secondarily
through caspase activation, ROS may directly contribute to the
reduction in the Ku protein and activate another oxidative
stress-triggered process. Previous studies show that ROS could
reduce the DNA repair activity (84) and directly damage the
DNA repair enzyme (25). In the case of severe oxidative DNA
damage against DNA repair, the activated p53 protein has
been shown to induce apoptosis directly or through the activa-
tion of other apoptosis-regulating genes, such as Bax (86, 87).
Li et al. (70) demonstrated that Ku80 inactivation resulted in
the induction of the tumor suppressor protein p53, which con-
tributed to the inhibition of cell growth. Our previous study
showed that ROS produced by Helicobacter pylori caused p53
and Bax expression and decreased Bcl-2 expression as well as
the nuclear loss of Ku70 and Ku80 in human adenocarcinoma
AGS cells.2 These results showed that the nuclear loss of Ku70
and Ku80 was related to the induction of p53 and Bax as well
as the decrease in Bcl-2 in the wild-type cells undergoing oxi-
dative stress-mediated apoptosis. In B cell chronic lympocytic
leukemia, the level of antiapoptotic Bcl-2 showed a positive
correlation with the Ku80 level (88). Both Ku70 and Ku80
expression was higher in aggressive breast tumor compared
with that in normal tissue (89), which suggests a possible
relationship among the levels of Bcl-2 and Ku70 and Ku80 and
anti-apoptosis in some cancer cells. As another subcellular
mechanism of apoptosis induced by the oxidative DNA damage,
PARP overactivation by severely damaged DNA may trigger
apoptosis through excessive energy consumption during DNA
repair (60, 90). The possible involvement of anti- and pro-
apoptotic molecules on Ku protein expression should be inves-
tigated in another study in relation to pancreatic acinar
cell death.
It was demonstrated that the inhibition of the Ku-DNA bind-
ing activity by the transfection of the C-terminal Ku80 (427–
732) expression gene resulted in an increase in apoptotic cell
death in AR42J cells. In other reports, Ku80 or Ku70 inactiva-
tion diminished the expression of the other Ku subunit (Ku70
or Ku80) and inhibited Ku-DNA binding as well as DNA-PK
activity in either Ku70 or Ku80-dificient cells (68–70). From
these results, it is postulated that the disruption of either Ku
subunit would reduce the Ku-DNA binding activity, which in-
hibits the functional role of the Ku proteins. Therefore, the
induction of apoptosis caused by the reduction in the nuclear
level of Ku70 and Ku80 may be related to the loss of the
Ku-DNA binding activity. This was proven by the result show-
ing that the inhibition of the Ku-DNA binding activity by the
transfection of the C-terminal Ku80 (427–732) resulted in an
increase in apoptotic cell death.
In this study, the G/GO-induced decrease in the nuclear
Ku70 and Ku80 levels were prevented in both the Ku70 cells
and the Ku80 cells. However, the prevention against G/GO-
induced loss of the nuclear Ku70 and Ku80 were more evident
in the Ku80 cells. The decrease in the number of viable cells
and the increase in DNA fragmentation induced by G/GO treat-
ment were inhibited similarly in both the Ku70 and Ku80
cells. These results demonstrate that both Ku70 and Ku80
contribute to the stability of the other Ku subunit. Feather-
stone and Jackson (23) demonstrated the similarities between
the Ku70 and Ku80 knockout mice because the two subunits
appear to work in a tight complex in vivo, and the loss of one
subunit of the Ku proteins destabilizes the other. The small
amount of Ku80 remaining in the Ku70 knockout cells can
promote DNA end joining by working as a monomer or ho-
modimer. In addition to the fact that Ku70 and Ku80 are the
primary partners for each other (85), the present results sug-
gest the sparing action of Ku proteins, as one subunit, may
stabilize the other subunit under the condition of the loss of
one subunit.
2 J. Y. Song, J. W. Lim, H. Kim, T. Morio, and K. H. Kim, unpublished
data.
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These results suggest that the oxidative stress-induced ap-
optosis may be mediated by the activated caspase-3, which
degrades the DNA repair protein Ku70 and Ku80, and the
decrease in Ku binding to nuclear transporter importin  and
importin , resulting in the reduced nuclear Ku proteins in
pancreatic acinar cells. The nuclear loss of Ku70 and Ku80 may
cause the loss of the defense against oxidative DNA damage,
which underlies the mechanism of apoptotic cell death in pan-
creatic acinar cells after oxidative stress.
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